Literature DB >> 30079989

Clinicians should stop prescribing sildenafil for fetal growth restriction (FGR): comment from the STRIDER Consortium.

K M Groom1, W Ganzevoort2, Z Alfirevic3, K Lim4, A T Papageorghiou5,6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30079989     DOI： 10.1002/uog.19186

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN： 0960-7692            Impact factor:   7.299


× No keyword cloud information.
  15 in total

1.  Maternal low molecular weight heparin versus sildenafil citrate for fetal growth restriction: a randomized, parallel groups, open-label clinical trial.

Authors:  R Rasheedy; G El Bishry; R Tarek
Journal:  J Perinatol       Date:  2019-11-06       Impact factor: 2.521

Review 2.  Preeclampsia beyond pregnancy: long-term consequences for mother and child.

Authors:  Hannah R Turbeville; Jennifer M Sasser
Journal:  Am J Physiol Renal Physiol       Date:  2020-04-06

3.  Effect of antenatal tetramethylpyrazine on lung development and YAP expression in rat model of experimental congenital diaphragmatic hernia.

Authors:  Junzuo Liao; Wenying Liu; Libin Zhang; Qin Li; Fang Hou; Pingjin Zou
Journal:  Int J Clin Exp Pathol       Date:  2020-01-01

4.  Prenatal Sildenafil Therapy Improves Cardiovascular Function in Fetal Growth Restricted Offspring of Dahl Salt-Sensitive Rats.

Authors:  Fieke Terstappen; Frank T Spradley; Bhavisha A Bakrania; Sinéad M Clarke; Jaap A Joles; Nina D Paauw; Michael R Garrett; A Titia Lely; Jennifer M Sasser
Journal:  Hypertension       Date:  2019-05       Impact factor: 10.190

5.  Tadalafil treatment for fetuses with early-onset growth restriction: a protocol for a multicentre, randomised, placebo-controlled, double-blind phase II trial (TADAFER IIb).

Authors:  Shintaro Maki; Hiroaki Tanaka; Sho Takakura; Masafumi Nii; Kayo Tanaka; Toru Ogura; Mayumi Kotera; Yuki Nishimura; Satoshi Tamaru; Takafumi Ushida; Yasuhiro Tanaka; Norihiko Kikuchi; Tadatsugu Kinjo; Hiroshi Kawamura; Mayumi Takano; Koji Nakamura; Sachie Suga; Michi Kasai; Osamu Yasui; Kenji Nagao; Yuka Maegawa; Tomomi Kotani; Masayuki Endo; Ichiro Yasuhi; Shigeru Aoki; Yoichi Aoki; Yoshio Yoshida; Masahiko Nakata; Akihiko Sekizawa; Tomoaki Ikeda
Journal:  BMJ Open       Date:  2022-06-14       Impact factor: 3.006

6.  A review of ex vivo placental perfusion models: an underutilized but promising method to study maternal-fetal interactions.

Authors:  Pinar Calis; Lucia Vojtech; Florian Hladik; Michael G Gravett
Journal:  J Matern Fetal Neonatal Med       Date:  2021-11-24

Review 7.  Challenges and Pitfalls: Performing Clinical Trials in Patients With Congenital Diaphragmatic Hernia.

Authors:  Suzan Cochius-den Otter; Jan A Deprest; Laurent Storme; Anne Greenough; Dick Tibboel
Journal:  Front Pediatr       Date:  2022-04-15       Impact factor: 3.569

8.  Protect-me: a parallel-group, triple blinded, placebo-controlled randomised clinical trial protocol assessing antenatal maternal melatonin supplementation for fetal neuroprotection in early-onset fetal growth restriction.

Authors:  Kirsten R Palmer; Joanne C Mockler; Miranda L Davies-Tuck; Suzanne L Miller; Stacy K Goergen; Michael C Fahey; Peter J Anderson; Katie M Groom; Euan M Wallace
Journal:  BMJ Open       Date:  2019-06-22       Impact factor: 2.692

9.  Antenatal sildenafil citrate treatment increases offspring blood pressure in the placental-specific Igf2 knockout mouse model of FGR.

Authors:  L J Renshall; E C Cottrell; E Cowley; C P Sibley; P N Baker; E B Thorstensen; S L Greenwood; M Wareing; M R Dilworth
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-12-06       Impact factor: 4.733

10.  Developmental Evaluation of Infants Who Have Received Tadalafil in Utero for Fetal Growth Restriction.

Authors:  Shintaro Maki; Ineko Kato; Naosuke Enomoto; Sho Takakura; Masafumi Nii; Kayo Tanaka; Hiroaki Tanaka; Shinsuke Hori; Kana Matsuda; Yukito Ueda; Hirofumi Sawada; Masahiro Hirayama; Akihiro Sudo; Tomoaki Ikeda
Journal:  J Clin Med       Date:  2020-05-13       Impact factor: 4.241
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.